UPDATE: La Jolla Pharma (LJPC) PT Raised to $54 at Chardan
Tweet Send to a Friend
(Updated - March 11, 2014 8:23 AM EDT)
Chardan Capital Markets analyst Ling Wang reiterated a Buy rating on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Chardan Capital Markets analyst Ling Wang reiterated a Buy rating on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


